Intellia Therapeutics
NTLA
NTLA
283 hedge funds and large institutions have $2.51B invested in Intellia Therapeutics in 2024 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 116 increasing their positions, 88 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 291 → 283 (-8)
3.02% less ownership
Funds ownership: 98.03% → 95.02% (-3%)
6% less capital invested
Capital invested by funds: $2.68B → $2.51B (-$163M)
Holders
283
Holding in Top 10
5
Calls
$21.7M
Puts
$23M
Top Buyers
| 1 | +$53.9M | |
| 2 | +$46.9M | |
| 3 | +$31.3M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$28.1M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$21M |
Top Sellers
| 1 | -$67.3M | |
| 2 | -$15.3M | |
| 3 | -$13.6M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$11.6M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$11.4M |